These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17058738)

  • 1. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up.
    Tsai PI; Ryan M; Meek K; Ryoo MC; Tome M; Takasugi J; Haigh P; Difronzo LA
    Am Surg; 2006 Oct; 72(10):929-34. PubMed ID: 17058738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience.
    DiFronzo LA; Tsai PI; Hwang JM; Lee JJ; Ryoo MC; Rahimian J; Tome M; Takasugi JK; Haigh PI
    Arch Surg; 2005 Aug; 140(8):787-94. PubMed ID: 16103290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
    Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
    Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
    Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
    Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
    Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
    Trombetta M; Hall M; Julian TB
    Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
    Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
    Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
    Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
    Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
    Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation.
    Shah NM; Wazer DE
    Semin Radiat Oncol; 2005 Apr; 15(2):100-7. PubMed ID: 15809935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.
    Jeruss JS; Kuerer HM; Beitsch PD; Vicini FA; Keisch M
    Ann Surg Oncol; 2011 Jan; 18(1):65-71. PubMed ID: 20577822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
    Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
    Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
    Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.